Literature DB >> 34505975

Lactobacillus rhamnosus Affects Rat Peritoneal Cavity Cell Response to Stimulation with Gut Microbiota: Focus on the Host Innate Immunity.

Stanislava Stanojević1,1, Veljko Blagojević2, Ivana Ćuruvija2, Vesna Vujić3.   

Abstract

Gut microbiota contribute to shaping the immune repertoire of the host, whereas probiotics may exert beneficial effects by modulating immune responses. Having in mind the differences in both the composition of gut microbiota and the immune response between rats of Albino Oxford (AO) and Dark Agouti (DA) rat strains, we investigated if intraperitoneal (i.p.) injection of live Lactobacillus rhamnosus (LB) may influence peritoneal cavity cell response to in vitro treatments with selected microbiota in the rat strain-dependent manner. Peritoneal cavity cells from AO and DA rats were lavaged two (d2) and seven days (d7) following i.p. injection with LB and tested for NO, urea, and H2O2 release basally, or upon in vitro stimulation with autologous E.coli and Enterococcus spp. Whereas the single i.p. injection of LB nearly depleted resident macrophages and increased the proportion of small inflammatory macrophages and monocytes on d2 in both rat strains, greater proportion of MHCIIhiCD163- and CCR7+ cells and increased NO/diminished H2O2 release in DA compared with AO rats suggest a more intense inflammatory priming by LB in this rat strain. Even though E.coli- and/or Enterococcus spp.-induced rise in H2O2 release in vitro was abrogated by LB in cells from both rat strains, LB prevented microbiota-induced increase in NO/urea ratio only in cells from AO and augmented it in cells from DA rats. Thus, the immunomodulatory properties may not be constant for particular probiotic bacteria, but shaped by innate immunity of the host.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Albino Oxford (AO) rats; Dark Agouti (DA) rats; E. coli; Enterococcus spp.; Lactobacillus rhamnosus; Peritoneal cavity immune cells

Mesh:

Substances:

Year:  2021        PMID: 34505975     DOI: 10.1007/s10753-021-01513-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  56 in total

1.  Rat strain differences in peritoneal immune cell response to selected gut microbiota: A crossroad between tolerance and autoimmunity?

Authors:  Veljko Blagojević; Vesna Kovačević-Jovanović; Ivana Ćuruvija; Raisa Petrović; Ivana Vujnović; Vesna Vujić; Stanislava Stanojević
Journal:  Life Sci       Date:  2018-02-08       Impact factor: 5.037

2.  Strain difference in susceptibility to experimental autoimmune encephalomyelitis between Albino Oxford and Dark Agouti rats correlates with disparity in production of IL-17, but not nitric oxide.

Authors:  Djordje Miljkovic; Stanislava Stosic-Grujicic; Milos Markovic; Miljana Momcilovic; Zorica Ramic; Danijela Maksimovic-Ivanic; Sanja Mijatovic; Dusan Popadic; Ivana Cvetkovic; Marija Mostarica-Stojkovic
Journal:  J Neurosci Res       Date:  2006-08-01       Impact factor: 4.164

3.  Reactive oxygen species (ROS), but not nitric oxide (NO), contribute to strain differences in the susceptibility to experimental arthritis in rats.

Authors:  Tatjana Miletić; Vesna Kovacević-Jovanović; Vesna Vujić; Stanislava Stanojević; Katarina Mitić; Mirjana Lazarević-Macanović; Mirjana Dimitrijević
Journal:  Immunobiology       Date:  2007-01-03       Impact factor: 3.144

4.  Peritoneal cavity is a route for gut-derived microbial signals to promote autoimmunity in non-obese diabetic mice.

Authors:  R Emani; C Alam; S Pekkala; S Zafar; M R Emani; A Hänninen
Journal:  Scand J Immunol       Date:  2015-02       Impact factor: 3.487

Review 5.  Rheumatoid arthritis-celiac disease relationship: joints get that gut feeling.

Authors:  Aaron Lerner; Torsten Matthias
Journal:  Autoimmun Rev       Date:  2015-07-17       Impact factor: 9.754

6.  Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis.

Authors:  S Stanisavljević; J Lukić; M Momčilović; M Miljković; B Jevtić; M Kojić; N Golić; M Mostarica Stojković; D Miljković
Journal:  Benef Microbes       Date:  2016-02-03       Impact factor: 4.205

Review 7.  Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.

Authors:  Patrice D Cani; Melania Osto; Lucie Geurts; Amandine Everard
Journal:  Gut Microbes       Date:  2012-05-14

8.  Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats.

Authors:  Suzana Stanisavljević; Jovanka Lukić; Svetlana Soković; Sanja Mihajlovic; Marija Mostarica Stojković; Djordje Miljković; Natasa Golić
Journal:  Front Microbiol       Date:  2016-12-15       Impact factor: 5.640

9.  Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity.

Authors:  Thomas B Clarke; Kimberly M Davis; Elena S Lysenko; Alice Y Zhou; Yimin Yu; Jeffrey N Weiser
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

10.  Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.

Authors:  Suzana Stanisavljević; Miroslav Dinić; Bojan Jevtić; Neda Đedović; Miljana Momčilović; Jelena Đokić; Nataša Golić; Marija Mostarica Stojković; Đorđe Miljković
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561

View more
  1 in total

1.  Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus.

Authors:  Yaowen Li; Yu Peng; Na Zhang; Huiping Liu; Jun Mao; Yisong Yan; Shuaishuai Wang; Guang Yang; Yanyan Liu; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2022-08-30       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.